Rocket Pharmaceuticals, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| RCKT | LXEO | SLDB | TNYA | RNA | RGNX | |
|---|---|---|---|---|---|---|
| Market cap | 272.24M | 249.55M | 719.48M | 126.80M | 140.44M | 512.92M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -1.9 | -2.2 | -3.9 | -1.4 | -1.0 | -2.6 |
| Price/book | 0.7 | 1.0 | 1.9 | 1.8 | 0.7 | 5.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −26.22% | −60.61% | +14.31% | −70.71% | −43.05% | −28.84% |
| Today | −3.13% | −5.88% | −2.33% | −2.55% | −2.26% | −3.72% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All RCKT news ›Cranbury biotech Rocket Pharmaceuticals lands credit facility for up to $150M from Hercules Capital
Gaurav Shah, M.D. - Rocket Pharmaceuticals Rocket Pharmaceuticals Inc., a biotechnology company advancing genetic medicines for rare and life-threatening diseases, announced Oct. 7 that it has entered into a credit facility agreement with…
Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Keeps Outperform Rating at Wedbush
Wedbush reiterated their outperform rating on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) in a research note published on Wednesday,Benzinga reports. View Our Latest Stock Report on RCKT Here are the key news stories…
Rocket Pharmaceuticals Announces Positive Clinical Safety Update from Initial Three Patients Treated with RP-A501 Under Modified Phase 2 Protocol for Danon Disease
Initial three patients were treated safely; RP-A501 was well-tolerated with no TMA or capillary leak syndrome observed Rocket is actively engaging with the FDA to align on the path to pivotal trial completion; regulatory pathway update…
All Transcripts on Middle East Pharmaceutical Industries Company (4016)
Find all the latest transcripts on Middle East Pharmaceutical Industries Company Transcripts Middle East Pharmaceutical Industries Company All financial news and data tailored to specific country editions
Rocket Pharmaceuticals Secures Credit Facility for Up to $150MM from Hercules Capital
Rocket Pharmaceuticals, a fully integrated, commercial-stage biotechnology company advancing genetic medicines for rare and life-threatening diseases, focused on inherited cardiovascular Rocket Pharmaceuticals, a fully integrated,…
Rocket Pharmaceuticals, Inc. Announces Executive Changes
Rocket Pharmaceuticals, Inc. announced that on June 24, 2026, John Militello informed the company of his resignation as Senior Controller, Treasurer and Principal Accounting Officer, effective July 7,... announced that on June 24, 2026,…
Rocket Pharmaceuticals, Inc. (RCKT) Discusses Danon Disease Program Update With Focus on RP-A501 Pivotal Trial and Preliminary Clinical Data Transcript
Rocket Pharmaceuticals, Inc. (RCKT) Discusses Danon Disease Program Update With Focus on RP-A501 Pivotal Trial and Preliminary Clinical Data October 6, 2026 4:30 PM EDT Meg Dodge - Senior Vice President & Head of External AffairsGaurav…
Rocket Pharmaceuticals' Danon, PKP2-ACM Updates Seen as Key H2 Catalysts, Wedbush Says
Rocket Pharmaceuticals' Q2 update confirmed its programs are on track, with management expecting regulatory updates on RP-A501 for Danon disease and RP-A601 for PKP2-ACM in H2, Wedbush Securities... Biotechnology & Medical Research Rocket…
Rocket Pharmaceuticals, Inc. : Insider Transactions
Follow insider transactions on Rocket Pharmaceuticals, Inc. in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions Rocket Pharmaceuticals, Inc. Biotechnology & Medical…
Transcript : Rocket Pharmaceuticals, Inc. - Special Call
Presentation Operator MessageOperator Good day, and welcome to the Rocket Pharmaceuticals Investor Program Update on Danon disease and the RP-A501 pivotal Phase II trial. As a reminder, today's... Transcript : Rocket Pharmaceuticals, Inc.…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com16
-
defenseworld.net5
-
stocktitan.net2
-
abfjournal.com1
-
gurufocus.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 29 articles, not a forecast.